|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-11-4
|
|
pubmed:abstractText |
It remains controversial whether positron emission tomography (PET) with 2-deoxy-2-[F-18]fluoro-D-glucose (F-18-FDG) can differentiate between benign and malignant musculoskeletal tumors. To uncover the mechanism of F-18-FDG accumulations, we analyzed the correlation between the F-18-FDG accumulation and the expression of glucose transporter 1 (Glut-1) and hexokinase II (HK-II) in benign and malignant musculoskeletal tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0914-7187
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
699-705
|
|
pubmed:meshHeading |
pubmed-meshheading:18982473-Adolescent,
pubmed-meshheading:18982473-Adult,
pubmed-meshheading:18982473-Aged,
pubmed-meshheading:18982473-Aged, 80 and over,
pubmed-meshheading:18982473-Bone Neoplasms,
pubmed-meshheading:18982473-Child,
pubmed-meshheading:18982473-Female,
pubmed-meshheading:18982473-Fluorodeoxyglucose F18,
pubmed-meshheading:18982473-Glucose Transporter Type 1,
pubmed-meshheading:18982473-Hexokinase,
pubmed-meshheading:18982473-Humans,
pubmed-meshheading:18982473-Male,
pubmed-meshheading:18982473-Middle Aged,
pubmed-meshheading:18982473-Muscle Neoplasms,
pubmed-meshheading:18982473-Positron-Emission Tomography,
pubmed-meshheading:18982473-Radiopharmaceuticals,
pubmed-meshheading:18982473-Reproducibility of Results,
pubmed-meshheading:18982473-Sensitivity and Specificity,
pubmed-meshheading:18982473-Statistics as Topic,
pubmed-meshheading:18982473-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
|
|
pubmed:affiliation |
Department of Orthopedic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article
|
